• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在 HIV 高发环境下模拟人群层面的异烟肼预防性治疗在结核病控制中的实施。

Modeling the implementation of population-level isoniazid preventive therapy for tuberculosis control in a high HIV-prevalence setting.

机构信息

Department of Biology.

Center for Population Health Sciences, Division of Primary Care and Population Health, Department of Medicine.

出版信息

AIDS. 2018 Sep 24;32(15):2129-2140. doi: 10.1097/QAD.0000000000001959.

DOI:10.1097/QAD.0000000000001959
PMID:30096067
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6150186/
Abstract

BACKGROUND

We model the epidemiological impact of providing isoniazid preventive therapy (IPT) to South African adolescents, among whom HIV prevalence is low, latent tuberculosis (TB) prevalence is high, and school-based programs may enable population-level coverage.

METHODS

We simulate a dynamic compartmental model of age-structured HIV and TB coepidemics in South Africa. HIV dynamics are modeled by infection status, CD4 cell count, and antiretroviral therapy; TB dynamics are modeled by disease stage, diagnosis, treatment, and IPT status. We analyze the effects of continuous IPT coverage among adolescents from 5 (baseline) to 90%.

RESULTS

Our model is calibrated to WHO and the Joint United Nations Programme on HIV/AIDS epidemiological estimates. In simulations, increasing IPT coverage to 50% among adolescents reduced active TB incidence by 5-34%. Increasing coverage to 90% led to a 9-40% reduction in active TB incidence. Expanded IPT access causes TB incidence to decline in the general population of HIV-positive individuals, as well as in adult HIV-positive individuals.

CONCLUSION

Targeting IPT to a secondary school population with high latent TB prevalence and low-HIV prevalence, in which risk of false-negative diagnosis of active TB is low and IPT benefits are more established, could have substantial benefits to adolescents and spillover benefits to the adult population.

摘要

背景

我们构建了模型,以评估在南非青少年中开展异烟肼预防性治疗(IPT)的流行病学影响。南非的青少年中 HIV 流行率低,潜伏性结核病(TB)流行率高,而学校为基础的项目可能实现人群层面的覆盖率。

方法

我们通过感染状态、CD4 细胞计数和抗逆转录病毒疗法来模拟南非年龄结构 HIV 和 TB 共流行的动态分组模型;通过疾病阶段、诊断、治疗和 IPT 状态来模拟 TB 动态。我们分析了从 5 岁(基线)到 90 岁的青少年连续接受 IPT 覆盖率的影响。

结果

我们的模型经过了世界卫生组织和联合国艾滋病规划署的流行病学估计值的校准。在模拟中,将青少年的 IPT 覆盖率从 50%增加到 90%,可使活动性 TB 发病率降低 9%至 40%。扩大 IPT 可及性会导致 HIV 阳性个体以及成人 HIV 阳性个体的 TB 发病率下降。

结论

IPT 针对潜伏性 TB 流行率高、HIV 流行率低的中学人群,假阴性诊断活动性 TB 的风险低,IPT 的获益更明确,这可能会对青少年产生重大影响,并对成年人群产生溢出效应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/983d/6150186/622db97cd3da/aids-32-2129-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/983d/6150186/95d702974153/aids-32-2129-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/983d/6150186/85bb0e48b2b3/aids-32-2129-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/983d/6150186/a54cd26b73d8/aids-32-2129-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/983d/6150186/622db97cd3da/aids-32-2129-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/983d/6150186/95d702974153/aids-32-2129-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/983d/6150186/85bb0e48b2b3/aids-32-2129-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/983d/6150186/a54cd26b73d8/aids-32-2129-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/983d/6150186/622db97cd3da/aids-32-2129-g004.jpg

相似文献

1
Modeling the implementation of population-level isoniazid preventive therapy for tuberculosis control in a high HIV-prevalence setting.在 HIV 高发环境下模拟人群层面的异烟肼预防性治疗在结核病控制中的实施。
AIDS. 2018 Sep 24;32(15):2129-2140. doi: 10.1097/QAD.0000000000001959.
2
Projected population-wide impact of antiretroviral therapy-linked isoniazid preventive therapy in a high-burden setting.在高负担地区,抗逆转录病毒治疗相关异烟肼预防性治疗的全人群影响预测。
AIDS. 2019 Mar 1;33(3):525-536. doi: 10.1097/QAD.0000000000002053.
3
Post-treatment effect of isoniazid preventive therapy on tuberculosis incidence in HIV-infected individuals on antiretroviral therapy.异烟肼预防性治疗对抗逆转录病毒治疗的HIV感染者结核病发病率的治疗后效果。
AIDS. 2016 May 15;30(8):1279-86. doi: 10.1097/QAD.0000000000001078.
4
Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.异烟肼预防性治疗对降低埃塞俄比亚亚的斯亚贝巴公共卫生设施中艾滋病毒/艾滋病感染者活动性结核病发病率的有效性:一项历史性队列研究。
BMC Infect Dis. 2017 Jan 3;17(1):5. doi: 10.1186/s12879-016-2109-7.
5
Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic.在结核病/艾滋病合并感染率不断下降的情况下,异烟肼连续预防性治疗的益处可能超过耐药风险。
AIDS. 2016 Nov 13;30(17):2715-2723. doi: 10.1097/QAD.0000000000001235.
6
Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study.坦桑尼亚 HIV 感染成人中异烟肼预防治疗对结核病发病率及相关危险因素的影响:一项回顾性队列研究。
BMC Infect Dis. 2019 Jan 17;19(1):62. doi: 10.1186/s12879-019-3696-x.
7
The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study.埃塞俄比亚吉马地区接受抗逆转录病毒治疗前护理的艾滋病毒感染者中,异烟肼预防性治疗对结核病发病率的影响:一项回顾性队列研究。
BMC Public Health. 2015 Apr 10;15:346. doi: 10.1186/s12889-015-1719-0.
8
Isoniazid Preventive Therapy for People With HIV Who Are Heavy Alcohol Drinkers in High TB-/HIV-Burden Countries: A Risk-Benefit Analysis.在高结核/艾滋病毒负担国家中,艾滋病毒感染者中重度饮酒者的异烟肼预防治疗:风险效益分析。
J Acquir Immune Defic Syndr. 2018 Apr 1;77(4):405-412. doi: 10.1097/QAI.0000000000001610.
9
A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda.异烟肼预防性治疗结局的前瞻性队列研究:乌干达一项全国性质量改进协作项目中的嵌套研究
AIDS Res Ther. 2020 May 27;17(1):28. doi: 10.1186/s12981-020-00285-0.
10
Implementation and Operational Research: Implementation of the WHO 2011 Recommendations for Isoniazid Preventive Therapy (IPT) in Children Living With HIV/AIDS: A Ugandan Experience.实施与运营研究:在乌干达实施世界卫生组织2011年针对感染艾滋病毒/艾滋病儿童的异烟肼预防性治疗(IPT)建议的经验。
J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):e1-8. doi: 10.1097/QAI.0000000000000806.

引用本文的文献

1
Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis.HIV 感染者中结核病预防治疗的经济学和建模证据:系统评价和荟萃分析。
PLoS Med. 2021 Sep 14;18(9):e1003712. doi: 10.1371/journal.pmed.1003712. eCollection 2021 Sep.
2
New opportunities in tuberculosis prevention: implications for people living with HIV.结核病预防的新机遇:对艾滋病毒感染者的影响。
J Int AIDS Soc. 2020 Jan;23(1):e25438. doi: 10.1002/jia2.25438.

本文引用的文献

1
Ability of preventive therapy to cure latent Mycobacterium tuberculosis infection in HIV-infected individuals in high-burden settings.高负担环境中预防性治疗治愈 HIV 感染者潜伏性结核分枝杆菌感染的能力。
Proc Natl Acad Sci U S A. 2014 Apr 8;111(14):5325-30. doi: 10.1073/pnas.1317660111. Epub 2014 Mar 24.
2
Disease control implications of India's changing multi-drug resistant tuberculosis epidemic.印度不断变化的耐多药结核病疫情对疾病控制的影响
PLoS One. 2014 Mar 7;9(3):e89822. doi: 10.1371/journal.pone.0089822. eCollection 2014.
3
Bacillus Calmette-Guérin and isoniazid preventive therapy protect contacts of patients with tuberculosis.
卡介苗和异烟肼预防治疗可保护结核患者的接触者。
Am J Respir Crit Care Med. 2014 Apr 1;189(7):853-9. doi: 10.1164/rccm.201310-1896OC.
4
A trial of mass isoniazid preventive therapy for tuberculosis control.大规模异烟肼预防治疗结核病控制的试验。
N Engl J Med. 2014 Jan 23;370(4):301-10. doi: 10.1056/NEJMoa1214289.
5
Data needs for evidence-based decisions: a tuberculosis modeler's 'wish list'.循证决策的数据需求:结核建模者的“愿望清单”。
Int J Tuberc Lung Dis. 2013 Jul;17(7):866-77. doi: 10.5588/ijtld.12.0573.
6
Community-wide isoniazid preventive therapy drives drug-resistant tuberculosis: a model-based analysis.全社区异烟肼预防治疗可推动耐药结核病的防控:基于模型的分析。
Sci Transl Med. 2013 Apr 10;5(180):180ra49. doi: 10.1126/scitranslmed.3005260.
7
Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis.抗反转录病毒疗法预防成人 HIV 感染者结核病:系统评价和荟萃分析。
PLoS Med. 2012;9(7):e1001270. doi: 10.1371/journal.pmed.1001270. Epub 2012 Jul 24.
8
Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis.结核分枝杆菌再感染后进展为活动性结核病的风险。
Clin Infect Dis. 2012 Mar;54(6):784-91. doi: 10.1093/cid/cir951. Epub 2012 Jan 19.
9
Burden of new and recurrent tuberculosis in a major South African city stratified by age and HIV-status.南非主要城市按年龄和 HIV 状况分层的新发病例和复发病例结核病负担。
PLoS One. 2011;6(10):e25098. doi: 10.1371/journal.pone.0025098. Epub 2011 Oct 10.
10
Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study.基层应用 Xpert MTB/RIF 检测诊断结核分枝杆菌感染和耐药的可行性、诊断准确性和效果:一项多中心实施研究。
Lancet. 2011 Apr 30;377(9776):1495-505. doi: 10.1016/S0140-6736(11)60438-8. Epub 2011 Apr 18.